192 related articles for article (PubMed ID: 21075916)
1. Continuing education course #3: current practices and future trends in neuropathology assessment for developmental neurotoxicity testing.
Bolon B; Garman RH; Gundersen HJ; Allan Johnson G; Kaufmann W; Krinke G; Little PB; Makris SL; Mellon RD; Sulik KK; Jensen K
Toxicol Pathol; 2011 Jan; 39(1):289-93. PubMed ID: 21075916
[TBL] [Abstract][Full Text] [Related]
2. A 'best practices' approach to neuropathologic assessment in developmental neurotoxicity testing--for today.
Bolon B; Garman R; Jensen K; Krinke G; Stuart B;
Toxicol Pathol; 2006; 34(3):296-313. PubMed ID: 16698729
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for harmonization of data collection and analysis of developmental neurotoxicity endpoints in regulatory guideline studies: Proceedings of workshops presented at Society of Toxicology and joint Teratology Society and Neurobehavioral Teratology Society meetings.
Li AA; Sheets LP; Raffaele K; Moser V; Hofstra A; Hoberman A; Makris SL; Garman R; Bolon B; Kaufmann W; Auer R; Lau E; Vidmar T; Bowers WJ
Neurotoxicol Teratol; 2017 Sep; 63():24-45. PubMed ID: 28757310
[TBL] [Abstract][Full Text] [Related]
4. Recommended Methods for Brain Processing and Quantitative Analysis in Rodent Developmental Neurotoxicity Studies.
Garman RH; Li AA; Kaufmann W; Auer RN; Bolon B
Toxicol Pathol; 2016 Jan; 44(1):14-42. PubMed ID: 26296631
[TBL] [Abstract][Full Text] [Related]
5. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
[TBL] [Abstract][Full Text] [Related]
6. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
[TBL] [Abstract][Full Text] [Related]
7. STP position paper: Recommended practices for sampling and processing the nervous system (brain, spinal cord, nerve, and eye) during nonclinical general toxicity studies.
Bolon B; Garman RH; Pardo ID; Jensen K; Sills RC; Roulois A; Radovsky A; Bradley A; Andrews-Jones L; Butt M; Gumprecht L
Toxicol Pathol; 2013; 41(7):1028-48. PubMed ID: 23475559
[TBL] [Abstract][Full Text] [Related]
8. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
Bal-Price A; Hogberg HT; Crofton KM; Daneshian M; FitzGerald RE; Fritsche E; Heinonen T; Hougaard Bennekou S; Klima S; Piersma AH; Sachana M; Shafer TJ; Terron A; Monnet-Tschudi F; Viviani B; Waldmann T; Westerink RHS; Wilks MF; Witters H; Zurich MG; Leist M
ALTEX; 2018; 35(3):306-352. PubMed ID: 29485663
[TBL] [Abstract][Full Text] [Related]
9. Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).
Terron A; Bennekou SH
Toxicol Appl Pharmacol; 2018 Sep; 354():19-23. PubMed ID: 29454059
[TBL] [Abstract][Full Text] [Related]
10. International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing.
Sachana M; Bal-Price A; Crofton KM; Bennekou SH; Shafer TJ; Behl M; Terron A
Toxicol Sci; 2019 Jan; 167(1):45-57. PubMed ID: 30476307
[TBL] [Abstract][Full Text] [Related]
11. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies.
Crofton KM; Makris SL; Sette WF; Mendez E; Raffaele KC
Neurotoxicol Teratol; 2004; 26(3):345-52. PubMed ID: 15113596
[TBL] [Abstract][Full Text] [Related]
12. Modern pathology methods for neural investigations.
Hale SL; Andrews-Jones L; Jordan WH; Jortner BS; Boyce RW; Boyce JT; Switzer RC; Butt MT; Garman RH; Jensen K; Krinke G; Little PB
Toxicol Pathol; 2011 Jan; 39(1):52-7. PubMed ID: 21212254
[TBL] [Abstract][Full Text] [Related]
13. International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes.
Bal-Price A; Crofton KM; Leist M; Allen S; Arand M; Buetler T; Delrue N; FitzGerald RE; Hartung T; Heinonen T; Hogberg H; Bennekou SH; Lichtensteiger W; Oggier D; Paparella M; Axelstad M; Piersma A; Rached E; Schilter B; Schmuck G; Stoppini L; Tongiorgi E; Tiramani M; Monnet-Tschudi F; Wilks MF; Ylikomi T; Fritsche E
Arch Toxicol; 2015 Feb; 89(2):269-87. PubMed ID: 25618548
[TBL] [Abstract][Full Text] [Related]
14. Regulatory Forum Opinion Piece*: Effective Brain Trimming for Regulatory-type Nonclinical Toxicity Studies.
Bolon B
Toxicol Pathol; 2018 Feb; 46(2):115-120. PubMed ID: 29278994
[TBL] [Abstract][Full Text] [Related]
15. STP Position Paper: Recommended Best Practices for Sampling, Processing, and Analysis of the Peripheral Nervous System (Nerves and Somatic and Autonomic Ganglia) during Nonclinical Toxicity Studies.
Bolon B; Krinke G; Butt MT; Rao DB; Pardo ID; Jortner BS; Garman RH; Jensen K; Andrews-Jones L; Morrison JP; Sharma AK; Thibodeau MS
Toxicol Pathol; 2018 Jun; 46(4):372-402. PubMed ID: 29787347
[TBL] [Abstract][Full Text] [Related]
16. Compilation of international regulatory guidance documents for neuropathology assessment during nonclinical general toxicity and specialized neurotoxicity studies.
Bolon B; Bradley A; Butt M; Jensen K; Krinke G; Mellon RD
Toxicol Pathol; 2011 Jan; 39(1):92-6. PubMed ID: 21119055
[TBL] [Abstract][Full Text] [Related]
17. Current problems of in vivo developmental neurotoxicity tests and a new in vivo approach focusing on each step of the developing central nervous system.
Kuwagata M
Congenit Anom (Kyoto); 2012 Sep; 52(3):129-39. PubMed ID: 22925213
[TBL] [Abstract][Full Text] [Related]
18. Integrating Data From In Vitro New Approach Methodologies for Developmental Neurotoxicity.
Carstens KE; Carpenter AF; Martin MM; Harrill JA; Shafer TJ; Paul Friedman K
Toxicol Sci; 2022 Apr; 187(1):62-79. PubMed ID: 35172012
[TBL] [Abstract][Full Text] [Related]
19. Developmental neuropathology in DNT-studies--a sensitive tool for the detection and characterization of developmental neurotoxicants.
Kaufmann W; Gröters S
Reprod Toxicol; 2006 Aug; 22(2):196-213. PubMed ID: 16781841
[TBL] [Abstract][Full Text] [Related]
20. A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review.
Juberg DR; Fox DA; Forcelli PA; Kacew S; Lipscomb JC; Saghir SA; Sherwin CM; Koenig CM; Hays SM; Kirman CR
Regul Toxicol Pharmacol; 2023 Sep; 143():105444. PubMed ID: 37442267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
